The role of high serum triglyceride levels on pancreatic necrosis development and related complications.
Acute pancreatitis
Hypertriglyceridemia
Pancreatic necrosis
Triglyceride
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
24 Feb 2023
24 Feb 2023
Historique:
received:
07
09
2022
accepted:
17
02
2023
entrez:
24
2
2023
pubmed:
25
2
2023
medline:
3
3
2023
Statut:
epublish
Résumé
The relevance of elevated serum triglyceride (TG) levels in the early stages of acute pancreatitis (AP) not induced by hypertriglyceridemia (HTG) remains unclear. Our study aims to determine the role of elevated serum TG levels at admission in developing pancreatic necrosis. We analyzed the clinical data collected prospectively from patients with AP. According to TG levels measured in the first 24 h after admission, we stratified patients into four groups: Normal TG (< 150 mg/dL), Borderline-high TG (150-199 mg/dL), High TG (200-499 mg/dL) and Very high TG (≥ 500 mg/dL). We analyzed the association of TG levels and other risk factors with the development of pancreatic necrosis. A total of 211 patients were included. In the Normal TG group: 122, in Borderline-high TG group: 38, in High TG group: 44, and in Very high TG group: 7. Pancreatic necrosis developed in 29.5% of the patients in the Normal TG group, 26.3% in the Borderline-high TG group, 52.3% in the High TG group, and 85.7% in the Very high TG group. The trend analysis observed a significant association between higher TG levels and pancreatic necrosis (p = 0.001). A multivariable analysis using logistic regression showed that elevated TG levels ≥ 200 mg/dL (High TG and Very high TG groups) were independently associated with pancreatic necrosis (OR: 3.27, 95% CI - 6.27, p < 0.001). An elevated TG level at admission ≥ 200 mg/dl is independently associated with the development of pancreatic necrosis. The incidence of pancreatic necrosis increases proportionally with the severity of HTG.
Sections du résumé
BACKGROUND
BACKGROUND
The relevance of elevated serum triglyceride (TG) levels in the early stages of acute pancreatitis (AP) not induced by hypertriglyceridemia (HTG) remains unclear. Our study aims to determine the role of elevated serum TG levels at admission in developing pancreatic necrosis.
METHODS
METHODS
We analyzed the clinical data collected prospectively from patients with AP. According to TG levels measured in the first 24 h after admission, we stratified patients into four groups: Normal TG (< 150 mg/dL), Borderline-high TG (150-199 mg/dL), High TG (200-499 mg/dL) and Very high TG (≥ 500 mg/dL). We analyzed the association of TG levels and other risk factors with the development of pancreatic necrosis.
RESULTS
RESULTS
A total of 211 patients were included. In the Normal TG group: 122, in Borderline-high TG group: 38, in High TG group: 44, and in Very high TG group: 7. Pancreatic necrosis developed in 29.5% of the patients in the Normal TG group, 26.3% in the Borderline-high TG group, 52.3% in the High TG group, and 85.7% in the Very high TG group. The trend analysis observed a significant association between higher TG levels and pancreatic necrosis (p = 0.001). A multivariable analysis using logistic regression showed that elevated TG levels ≥ 200 mg/dL (High TG and Very high TG groups) were independently associated with pancreatic necrosis (OR: 3.27, 95% CI - 6.27, p < 0.001).
CONCLUSIONS
CONCLUSIONS
An elevated TG level at admission ≥ 200 mg/dl is independently associated with the development of pancreatic necrosis. The incidence of pancreatic necrosis increases proportionally with the severity of HTG.
Identifiants
pubmed: 36829113
doi: 10.1186/s12876-023-02684-9
pii: 10.1186/s12876-023-02684-9
pmc: PMC9955530
doi:
Substances chimiques
Triglycerides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
51Informations de copyright
© 2023. The Author(s).
Références
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
J Biol Chem. 2014 Aug 22;289(34):23582-95
pubmed: 24993827
Exp Ther Med. 2017 Nov;14(5):4397-4404
pubmed: 29104650
Adv Intern Med. 1969;15:117-54
pubmed: 4908616
Ann Epidemiol. 2007 Jul;17(7):491-7
pubmed: 17448682
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5525-5528
pubmed: 34533798
Medicine (Baltimore). 2022 Jan 14;101(2):e28471
pubmed: 35029194
Arch Endocrinol Metab. 2017 Mar-Apr;61(2):198-201
pubmed: 28225998
Dig Surg. 2006;23(5-6):336-44; discussion 344-5
pubmed: 17164546
Sci Rep. 2020 Oct 21;10(1):17936
pubmed: 33087766
Pancreatology. 2001;1(2):79-89
pubmed: 12120191
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Pancreas. 2008 Jul;37(1):13-2
pubmed: 18580438
Am J Gastroenterol. 2015 Dec;110(12):1707-16
pubmed: 26553208
Hepatogastroenterology. 2012 Oct;59(119):2318-26
pubmed: 22389298
Clin Gastroenterol Hepatol. 2011 Dec;9(12):1098-103
pubmed: 21893128
Am J Gastroenterol. 2006 Oct;101(10):2379-400
pubmed: 17032204
Crit Care Med. 1995 Oct;23(10):1638-52
pubmed: 7587228
Pancreas. 2000 May;20(4):367-72
pubmed: 10824690
HPB Surg. 2013;2013:367581
pubmed: 24204087
Pancreatology. 2011;11(2):92-8
pubmed: 21577040
World J Gastroenterol. 2008 Jul 28;14(28):4558-61
pubmed: 18680239
Kidney Int. 2006 Nov;70(9):1560-6
pubmed: 16955100
J Biol Chem. 2012 Jan 13;287(3):1823-36
pubmed: 22128146
Acta Physiol (Oxf). 2009 Jan;195(1):13-28
pubmed: 18983441
Gastroenterology. 2011 Oct;141(4):1254-63
pubmed: 21741922
United European Gastroenterol J. 2018 Jun;6(5):649-655
pubmed: 30083325
Pancreatology. 2009;9(3):252-7
pubmed: 19407479
Gut. 2014 May;63(5):818-31
pubmed: 23929695
Am J Gastroenterol. 1998 Nov;93(11):2130-4
pubmed: 9820385
Radiology. 1990 Feb;174(2):331-6
pubmed: 2296641
BMC Endocr Disord. 2012 Mar 31;12:2
pubmed: 22463676
Diabetologia. 2012 May;55(5):1526-34
pubmed: 22327285
J Dig Dis. 2021 Jan;22(1):41-48
pubmed: 33184988
Am J Pathol. 2015 Mar;185(3):808-19
pubmed: 25579844
Gastroenterology. 2019 May;156(7):1994-2007.e3
pubmed: 30776347
Pancreas. 1991 May;6(3):253-9
pubmed: 1713669
Pancreatology. 2015 Jul-Aug;15(4):313-20
pubmed: 25800175
AJR Am J Roentgenol. 2004 Nov;183(5):1261-5
pubmed: 15505289
Am J Gastroenterol. 1995 Dec;90(12):2134-9
pubmed: 8540502
Eur J Intern Med. 2014 Oct;25(8):689-94
pubmed: 25269432
J Clin Lipidol. 2012 Sep-Oct;6(5):409-12
pubmed: 23009776
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2192-2198
pubmed: 33965573
Int J Mol Sci. 2017 Oct 25;18(11):
pubmed: 29068376
Am J Gastroenterol. 2015 Oct;110(10):1497-503
pubmed: 26323188
Int J Obes (Lond). 2006 Jun;30(6):899-905
pubmed: 16446749
J Lipid Res. 2008 Sep;49(9):2055-62
pubmed: 18509197
Pancreatology. 2018 Jul;18(5):486-493
pubmed: 29802078
Indian J Endocrinol Metab. 2013 Sep;17(5):799-805
pubmed: 24083160
Pancreas. 2000 Apr;20(3):319-22
pubmed: 10766460
Arch Surg. 1993 May;128(5):586-90
pubmed: 8489394
World J Emerg Surg. 2019 Jun 13;14:27
pubmed: 31210778
BMC Gastroenterol. 2015 Feb 14;15:19
pubmed: 25887309
Arch Intern Med. 2011 Apr 11;171(7):669-76
pubmed: 21482842
World J Surg. 2022 Jul;46(7):1758-1767
pubmed: 35355100
Eur J Intern Med. 2013 Apr;24(3):203-6
pubmed: 23375619
Can J Gastroenterol Hepatol. 2015 Dec 14;:
pubmed: 26668823
World J Gastrointest Surg. 2019 Apr 27;11(4):198-217
pubmed: 31123558
Cleve Clin J Med. 2017 Aug;84(8):639-648
pubmed: 28806163
Gastroenterology. 2020 Jan;158(1):67-75.e1
pubmed: 31479658
Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15
pubmed: 24054878
Am J Gastroenterol. 2009 Jan;104(1):164-70
pubmed: 19098865
Sci Transl Med. 2011 Nov 2;3(107):107ra110
pubmed: 22049070